Therapeutic Advances in Drug Safety Q1 Unclaimed
Therapeutic Advances in Drug Safety is a journal indexed in SJR in Pharmacology (medical) with an H index of 46. It is an CC BY-NC Journal with a Single blind Peer Review review system The scope of the journal is focused on drug safety, clinical toxicology, pharmacology, pharmacotherapeutics. It has an SJR impact factor of 1,035 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,035.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,035
SJR Impact factor46
H Index27
Total Docs (Last Year)103
Total Docs (3 years)1296
Total Refs396
Total Cites (3 years)91
Citable Docs (3 years)3.07
Cites/Doc (2 years)48.0
Ref/DocOther journals with similar parameters
Drug Resistance Updates Q1
Pharmacology and Therapeutics Q1
Alimentary Pharmacology and Therapeutics Q1
American Journal of Transplantation Q1
Journal of Biomedical Science Q1
Compare this journals
Aims and Scope
Best articles by citations
Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting
View moreCombined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks
View moreValidity of electronic hospital discharge prescription records as a source of medication data for pharmacoepidemiological research
View moreNew antiepileptic medication linked to blue discoloration of the skin and eyes
View morePharmacists in Australian general practice: an opportunity for expertise in precision medicine
View moreManaging acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined
View moreIdentifying and assessing potential harm of medication errors and potentially unsafe medication practices in paediatric hospital settings: a field study
View moreBisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy
View moreThe impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study
View moreDofetilide-induced anorexia in an older adult
View moreDrug safety advances from ICPE 2010
View moreQT interval prolongation and torsades de pointes with oxaliplatin
View moreUse of doripenem and risk of seizure and renal impairment in US hospitalized patients: a retrospective cohort study
View moreOn the integration and standardization of medication error data: taxonomies, terminologies, causes and contributing factors
View moreEducational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria
View moreRevisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance
View moreSafety of drugs used in the treatment of osteoporosis
View moreA review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks
View moreRoadmap to risk evaluation and mitigation strategies (REMS) success
View moreOpioid formulations with sequestered naltrexone: a perspective review
View moreComparison of bleeding risks among non-vitamin K antagonist oral anticoagulants using the Korea adverse event reporting system database
View moreProfound hyperkalemia associated with thromboprophylactic enoxaparin
View moreSensitivity to warfarin following cardiac surgery
View moreSecukinumab-induced Raynaud's phenomenon: first report in the literature
View more
Comments